Top 10 Nebivolol (Bystolic) Generic Manufacturers in Canada

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:
In Canada, the market for Nebivolol (Bystolic) generics has been steadily growing in recent years. With an increasing focus on cost-effective alternatives to brand-name medications, generic manufacturers have been playing a significant role in meeting the demand for affordable healthcare solutions. According to recent statistics, the Canadian pharmaceutical market is expected to reach $25.7 billion by 2023, with generic drugs accounting for a significant portion of this growth.

Top 10 Nebivolol (Bystolic) Generic Manufacturers in Canada:

1. Apotex Inc.
Apotex Inc. is a leading generic pharmaceutical company in Canada, with a production volume of over 22 million units of Nebivolol generics annually. The company’s commitment to quality and affordability has made them a trusted name in the industry.

2. Teva Canada
Teva Canada is another major player in the Nebivolol generics market, with a market share of 15% in Canada. The company’s focus on innovation and research has helped them stay competitive in the market.

3. Sandoz Canada
Sandoz Canada is known for its high-quality generic medications, including Nebivolol generics. The company’s exports of Nebivolol generics to other countries have been steadily growing over the years.

4. Pharmascience Inc.
Pharmascience Inc. is a Canadian pharmaceutical company that has been producing Nebivolol generics for over a decade. The company’s commitment to sustainability and social responsibility has helped them gain a competitive edge in the market.

5. Mylan Pharmaceuticals
Mylan Pharmaceuticals is a global leader in generic medications, including Nebivolol generics. The company’s strong distribution network in Canada has helped them reach a wide customer base.

6. Laboratoires Riva Inc.
Laboratoires Riva Inc. is a Quebec-based pharmaceutical company that specializes in generic medications. The company’s focus on customer satisfaction and quality control has helped them establish a strong presence in the Nebivolol generics market.

7. Cobalt Pharmaceuticals
Cobalt Pharmaceuticals is a Canadian generic drug manufacturer that produces Nebivolol generics for the domestic market. The company’s dedication to research and development has helped them stay ahead of the competition.

8. Pendopharm
Pendopharm is a subsidiary of Pharmascience Inc. that specializes in the production of generic medications, including Nebivolol generics. The company’s focus on customer service and product quality has made them a preferred choice among healthcare providers.

9. Pro Doc
Pro Doc is a Quebec-based pharmaceutical company that manufactures Nebivolol generics for the Canadian market. The company’s commitment to innovation and affordability has helped them gain a competitive edge in the industry.

10. Ratiopharm
Ratiopharm is a subsidiary of Teva Canada that produces a wide range of generic medications, including Nebivolol generics. The company’s strong presence in the Canadian market has helped them become a trusted name among healthcare providers.

Insights:
The market for Nebivolol (Bystolic) generics in Canada is expected to continue growing in the coming years, driven by factors such as increasing healthcare costs and the demand for affordable medications. With the rise of chronic diseases and an aging population, the need for cost-effective healthcare solutions will only continue to grow. Pharmaceutical companies that focus on innovation, quality, and affordability will be well-positioned to capitalize on this trend. According to industry experts, the Canadian pharmaceutical market is projected to grow at a CAGR of 3.5% from 2021 to 2026, with generic drugs playing a significant role in this growth. As such, the top generic manufacturers in Canada will need to continue to innovate and adapt to meet the changing needs of the market.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →